Description
Cagrilintide
A research peptide studied for appetite control, weight-management support, and metabolic response.
Product Overview
- Compound: Cagrilintide
- Available strengths: 5 mg, 10 mg
- Injection type: Subcutaneous
- Frequency: Once per week
Dosing Guide by Strength
5 mg vial: mix with 1 mL BAC water • 0.05 mg per unit • 300 mcg to 4.5 mg = 6 to 90 units
10 mg vial: mix with 2 mL BAC water • 0.05 mg per unit • 300 mcg to 4.5 mg = 6 to 90 units
Recommended Dose
300 mcg to 4.5 mg
Approximately 6 to 90 units depending on titration stage
Notes
Subcutaneous injection. Can be added to GLP protocols to help reduce required GLP dosage.
Disclaimer
This product is intended for research and informational purposes only.
Reviews
There are no reviews yet.